The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Abstract
BACKGROUND: MicroRNA expression profiles can be used to distinguish normal B cells from malignant B cells in patients with chronic lymphocytic leukemia (CLL). We investigated whether microRNA profiles are associated with known prognostic factors in CLL. METHODS: We evaluated the microRNA expression profiles of 94 samples of CLL cells for which the level of expression of 70-kD zeta-associated protein (ZAP-70), the mutational status of the rearranged immunoglobulin heavy-chain variable-region (IgV(H) ) gene, and the time from diagnosis to initial treatment were known. We also investigated the genomic sequence of 42 microRNA genes to identify abnormalities. RESULTS: A unique microRNA expression signature composed of 13 genes (of 190 analyzed) differentiated cases of CLL with low levels of ZAP-70 expression from those with high levels and cases with unmutated IgV(H) from those with mutated IgV(H) . The same microRNA signature was also associated with the presence or absence of disease progression. We also identified a germ-line mutation in the miR-16-1-miR-15a primary precursor, which caused low levels of microRNA expression in vitro and in vivo and was associated with deletion of the normal allele. Germ-line or somatic mutations were found in 5 of 42 sequenced microRNAs in 11 of 75 patients with CLL, but no such mutations were found in 160 subjects without cancer (P<0.001). CONCLUSIONS: A unique microRNA signature is associated with prognostic factors and disease progression in CLL. Mutations in microRNA transcripts are common and may have functional importance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Self-citationMicroarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Self-citationGenomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,318
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
Cited by
Items 201–267 of 267
Ji, J., Zhang, J., Huang, G., Qian, J., Wang, X., & Mei, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.034 · Cited by 293
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Li, W., Xie, L., He, X., Li, J., Tu, K., Wei, L., Wu, J., Guo, Y., Ma, X., Zhang, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23693 · Cited by 293
A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma
Weber, F., Teresi, R. E., Broelsch, C. E., Frilling, A., & Eng, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0693 · Cited by 293
Costinean, S., Sandhu, S. K., Pedersen, I. M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J., Kauffman, L. R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-220814 · Cited by 292
Self-citationmicroRNAs: Master Regulators as Potential Therapeutics in Cancer
Garofalo, M., & Croce, C. M. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100517 · Cited by 291
Self-citationMicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Garofalo, M., Quintavalle, C., Di Leva, G., Zanca, C., Romano, G., Taccioli, C., Liu, C. G., Croce, C. M., & Condorelli, G. (2008) · Oncogene · doi:10.1038/onc.2008.6 · Cited by 289
Self-citationPu, X., Huang, G., Guo, H., Guo, C., Li, H., Ye, S., Ling, S., Jiang, L., Tian, Y., & Lin, T. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06417.x · Cited by 289
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
Takagi, T., Iio, A., Nakagawa, Y., Naoe, T., Tanigawa, N., & Akao, Y. (2009) · Oncology · doi:10.1159/000218166 · Cited by 287
Park, J.-K., Lee, E. J., Esau, C., & Schmittgen, T. D. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181ba82e1 · Cited by 287
Xu, Q., Jiang, Y., Yin, Y., Li, Q., He, J., Jing, Y., Qi, Y.-T., Xu, Q., Li, W., Lu, B., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs049 · Cited by 285
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
Lanza, G., Ferracin, M., Gafà, R., Veronese, A., Spizzo, R., Pichiorri, F., Liu, C.-G., Calin, G. A., Croce, C. M., & Negrini, M. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-54 · Cited by 285
Self-citationDownregulation of microRNAs‐143 and ‐145 in B‐cell malignancies
Akao, Y., Nakagawa, Y., Kitade, Y., Kinoshita, T., & Naoe, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00618.x · Cited by 285
Emerging Role of MicroRNAs in Cardiovascular Biology
Latronico, M. V. G., Catalucci, D., & Condorelli, G. (2007) · Circulation Research · doi:10.1161/circresaha.107.163147 · Cited by 284
Functional aspects of animal microRNAs
Williams, A. E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7355-9 · Cited by 282
Lu, L., Katsaros, D., Rigault de la Longrais, I. A., Sochirca, O., & Yu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2544 · Cited by 282
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice
Raveche, E. S., Salerno, E., Scaglione, B. J., Manohar, V., Abbasi, F., Lin, Y.-C., Fredrickson, T., Landgraf, P., Ramachandra, S., Huppi, K., et al. (2007) · Blood · doi:10.1182/blood-2007-02-071225 · Cited by 281
Yang, X., Liang, L., Zhang, X.-F., Jia, H.-L., Qin, Y., Zhu, X.-C., Gao, X.-M., Qiao, P., Zheng, Y., Sheng, Y.-Y., et al. (2013) · Hepatology · doi:10.1002/hep.26305 · Cited by 280
MicroRNA expression profiles in head and neck cancer cell lines
Tran, N., McLean, T., Zhang, X., Zhao, C. J., Thomson, J. M., O’Brien, C., & Rose, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.201 · Cited by 275
MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines
Bemis, L. T., Chen, R., Amato, C. M., Classen, E. H., Robinson, S. E., Coffey, D. G., Erickson, P. F., Shellman, Y. G., & Robinson, W. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2912 · Cited by 273
Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis
Berezikov, E., van Tetering, G., Verheul, M., van de Belt, J., van Laake, L., Vos, J., Verloop, R., van de Wetering, M., Guryev, V., Takada, S., et al. (2006) · Genome Research · doi:10.1101/gr.5159906 · Cited by 273
A microRNA component of the hypoxic response
Kulshreshtha, R., Davuluri, R. V., Calin, G. A., & Ivan, M. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402310 · Cited by 272
Self-citationOsaki, M., Takeshita, F., Sugimoto, Y., Kosaka, N., Yamamoto, Y., Yoshioka, Y., Kobayashi, E., Yamada, T., Kawai, A., Inoue, T., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.53 · Cited by 271
The prognostic and functional role of microRNAs in acute myeloid leukemia
Marcucci, G., Mrózek, K., Radmacher, M. D., Garzon, R., & Bloomfield, C. D. (2011) · Blood · doi:10.1182/blood-2010-09-191312 · Cited by 270
Self-citationEpigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells
Saito, Y., & Jones, P. M. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3340 · Cited by 270
Bioluminescence-Based Detection of MicroRNA, miR21 in Breast Cancer Cells
Cissell, K. A., Rahimi, Y., Shrestha, S., Hunt, E. A., & Deo, S. K. (2008) · Analytical Chemistry · doi:10.1021/ac702577a · Cited by 268
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma
Cervigne, N. K., Reis, P. P., Machado, J., Sadikovic, B., Bradley, G., Galloni, N. N., Pintilie, M., Jurisica, I., Perez-Ordonez, B., Gilbert, R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp446 · Cited by 268
MicroRNAs, macrocontrol: Regulation of miRNA processing
Slezak-Prochazka, I., Durmus, S., Kroesen, B.-J., & van den Berg, A. (2010) · RNA · doi:10.1261/rna.1804410 · Cited by 267
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Manier, S., Liu, C.-J., Avet-Loiseau, H., Park, J., Shi, J., Campigotto, F., Salem, K. Z., Huynh, D., Glavey, S. V., Rivotto, B., et al. (2017) · Blood · doi:10.1182/blood-2016-09-742296 · Cited by 266
Self-citationMicromarkers: miRNAs in cancer diagnosis and prognosis
Ferracin, M., Veronese, A., & Negrini, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.11 · Cited by 266
Self-citationImplications of micro-RNA profiling for cancer diagnosis
Cummins, J. M., & Velculescu, V. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209914 · Cited by 266
MicroRNA and cancer: Current status and prospective
Wu, W., Sun, M., Zou, G., & Chen, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22454 · Cited by 266
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H., & Huang, Y. (2009) · Rheumatology International · doi:10.1007/s00296-008-0758-6 · Cited by 265
Chiorazzi, N., & Ferrarini, M. (2011) · Blood · doi:10.1182/blood-2010-07-155663 · Cited by 264
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Ng, E. K. O., Li, R., Shin, V. Y., Jin, H. C., Leung, C. P. H., Ma, E. S. K., Pang, R., Chua, D., Chu, K.-M., Law, W. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053141 · Cited by 263
Henao-Mejia, J., Williams, A., Goff, L. A., Staron, M., Licona-Limón, P., Kaech, S. M., Nakayama, M., Rinn, J. L., & Flavell, R. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.021 · Cited by 263
Roles of small RNAs in tumor formation
Di Leva, G., & Croce, C. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.001 · Cited by 262
Self-citationGAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3503 · Cited by 262
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 260
Mishra, P. J., & Bertino, J. R. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.3.399 · Cited by 260
Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E., Wu, M., & Shen, S.-H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm480 · Cited by 259
Wang, T., Zhang, X., Obijuru, L., Laser, J., Aris, V., Lee, P., Mittal, K., Soteropoulos, P., & Wei, J. (2007) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20415 · Cited by 257
Malumbres, R., Sarosiek, K. A., Cubedo, E., Ruiz, J. W., Jiang, X., Gascoyne, R. D., Tibshirani, R., & Lossos, I. S. (2009) · Blood · doi:10.1182/blood-2008-10-184077 · Cited by 252
MicroRNAs: biomarkers, diagnostics, and therapeutics
Huang, W. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_4 · Cited by 237
Forrest, A. R. R., Kanamori-Katayama, M., Tomaru, Y., Lassmann, T., Ninomiya, N., Takahashi, Y., de Hoon, M. J. L., Kubosaki, A., Kaiho, A., Suzuki, M., et al. (2010) · Leukemia · doi:10.1038/leu.2009.246 · Cited by 223
MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a
Zhang, Y., Chao, T., Li, R., Liu, W., Chen, Y., Yan, X., Gong, Y., Yin, B., Liu, W., Qiang, B., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0403-6 · Cited by 218
Diverse human extracellular RNAs are widely detected in human plasma
Freedman, J. E., Gerstein, M., Mick, E., Rozowsky, J., Levy, D., Kitchen, R., Das, S., Shah, R., Danielson, K., Beaulieu, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11106 · Cited by 202
“While a strength of our study is that the large numbers allow greater confidence if potential sample preparation contamination occurred, this study, as with all Predicted miRNA targets Factor 3 Factor 2 Factor 1 Factor 4 (7,293) (12,166) (9,530) (6,539)”
ResultSkalsky, R. L., & Cullen, B. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024248 · Cited by 170
MicroRNA signature and regulatory functions in the endometrium during normal and disease states
Pan, Q., & Chegini, N. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-0028-1096128 · Cited by 134
“3, a region that is deleted and/or downregulated in several disorders, with germ-line mutation identified in miR-16–1 precursor associated with low level of miR-16–1 expression in chronic lymphocytic leukemia.(123) The expression of miR-15a and miR-16–1 Figure 2 The aberrant endometrial expression of these miRNAs due…”
BackgroundFerraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Vlassi, M., Spyridakis, Y., Tsipras, I., Zografos, G., et al. (2014) · Epigenetics · doi:10.4161/epi.26842 · Cited by 111
Everything you wanted to know about small RNA but were afraid to ask
Boyd, S. D. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.32 · Cited by 108
Technical variables in high-throughput miRNA expression profiling: much work remains to be done
NELSON, P., WANG, W., WILFRED, B., & TANG, G. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.03.012 · Cited by 92
Expression profiling of microRNA using oligo DNA arrays
Liu, C.-G., Spizzo, R., Calin, G. A., & Croce, C. M. (2008) · Methods · doi:10.1016/j.ymeth.2007.10.010 · Cited by 84
Self-citationCosta, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80
miR-138 might reverse multidrug resistance of leukemia cells
Zhao, X., Yang, L., Hu, J., & Ruan, J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2009.10.002 · Cited by 79
Du, L., Schageman, J. J., Irnov, Girard, L., Hammond, S. M., Minna, J. D., Gazdar, A. F., & Pertsemlidis, A. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-75 · Cited by 73
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia
Xu, C., Fu, H., Gao, L., Wang, L., Wang, W., Li, J., Li, Y., Dou, L., Gao, X., Luo, X., et al. (2014) · Oncogene · doi:10.1038/onc.2012.557 · Cited by 58
Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system
Chen, L. S., Balakrishnan, K., & Gandhi, V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.039 · Cited by 55
“First, the most consistent cytogenetic lesion in CLL is chromosomal deletions of 13q14 [21], resulting in loss of microRNAs (miR-15, miR-16) that down-regulate Bcl-2 mRNA levels [22, 23].”
BackgroundLi, B., Sun, M., Gao, F., Liu, W., Yang, Y., Liu, H., Cheng, Y., Liu, C., & Cai, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356607 · Cited by 54
Self-citationGonzalez-Villasana, V., Rashed, M. H., Gonzalez-Cantú, Y., Bayraktar, R., Menchaca-Arredondo, J. L., Vazquez-Guillen, J. M., Rodriguez-Padilla, C., Lopez-Berestein, G., & Resendez-Perez, D. (2019) · Disease Markers · doi:10.1155/2019/6852917 · Cited by 53
Erythroleukemia-historical perspectives and recent advances in diagnosis and management
Boddu, P., Benton, C. B., Wang, W., Borthakur, G., Khoury, J. D., & Pemmaraju, N. (2018) · Blood Reviews · doi:10.1016/j.blre.2017.09.002 · Cited by 49
Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group
Wang, W.-X., Kyprianou, N., Wang, X., & Nelson, P. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1684 · Cited by 48
Consequences of genetic variants in miRNA genes
Machowska, M., Galka-Marciniak, P., & Kozlowski, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.036 · Cited by 40
The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia
Duhamel, M., Arrouss, I., Merle-Béral, H., & Rebollo, A. (2008) · Blood · doi:10.1182/blood-2007-09-113191 · Cited by 33
Noncoding RNA mutations in cancer
Zhou, H., Hao, X., Zhang, P., & He, S. (2023) · WIREs RNA · doi:10.1002/wrna.1812 · Cited by 24
Small Non-Coding RNAs in Leukemia
Balatti, V., & Croce, C. M. (2022) · Cancers · doi:10.3390/cancers14030509 · Cited by 14
Self-citation(2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
(2008) · PubMed
Metadata
- Authors
- Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C.-G., Kipps, T. J., Negrini, M., & Croce, C. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-27
- Volume
- 353
- Issue
- 17
- Pages
- 1793-1801
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2075329854
- Cited by
- 2,403
- References
- 30
- FWCI
- 58.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.